Abbas Guven Akcay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Abbas Guven Akcay has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Ali Osmay Gure
Department of Medical Biology, Acibadem University, 34684 Istanbul, Turkey
1 shared publication - Baris Kucukkaraduman
Department of Molecular Biology and Genetics, Bilkent University, Ankara 06800, Turkey
1 shared publication - Ege Dedeoglu
Department of Molecular Biology and Genetics, Bilkent University, Ankara, Turkey
1 shared publication Hasim Hakanoglu
Department of Molecular Biology and Genetics, Bilkent University, Ankara, Turkey
1 shared publication- Isli Cela
Department of Molecular Biology and Genetics, Bilkent University, Ankara, Turkey
1 shared publication - Muhammad Waqas Akbar
Department of Molecular Biology and Genetics, Bilkent University, Ankara, Turkey
1 shared publication
Latest Publications
- Open Access
Plasticity as an Underlying Mechanism of Tumor Heterogeneity in Breast Cancer
Breast cancer shows plasticity in terms of classification. Upon drug treatment and metastasis some tumors switch to another subtype leading to loss of response to therapy. In this study, we ask the question which molecular subclasses of breast cancer are more switchable upon drug therapy and metastasis. We used in silico data to classify breast cancer tumors in PAM50 molecular classes before treatment and after treatment using gene expression data. Similar analysis was performed for primary tumors and their metastatic growth. Our analysis showed that in both scenarios some breast tumors shift from one class to another. This suggests that patients who underwent chemotherapy but resulted in relapse or/and metastasis should be retyped for molecular subclass so that treatment protocol should be adopted according to those subtypes. Additionally, 20 genes were identified as biomarkers for metastasis in breast cancer.
Open AccessPlasticity as an Underlying Mechanism of Tumor Heterogeneity in Breast Cancer
Breast cancer shows plasticity in terms of classification. Upon drug treatment and metastasis some tumors switch to another subtype leading to loss of response to therapy. In this study, we ask the question which molecular subclasses of breast cancer are more switchable upon drug therapy and metastasis. We used in silico data to classify breast cancer tumors in PAM50 molecular classes before treatment and after treatment using gene expression data. Similar analysis was performed for primary tumors and their metastatic growth. Our analysis showed that in both scenarios some breast tumors shift from one class to another. This suggests that patients who underwent chemotherapy but resulted in relapse or/and metastasis should be retyped for molecular subclass so that treatment protocol should be adopted according to those subtypes. Additionally, 20 genes were identified as biomarkers for metastasis in breast cancer.